Clinical trial

Tirzepatide in PWS, HO and GNSO

NCT06901245

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2025-05-01

PhasePHASE4

Study timeline

Study start (actual)2025-05-01Date precision: day

Registry last updated2025-09-16

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Prader-Willi Syndromeunresolved

Hypothalamic Obesityunresolved

Obesity/Therapyunresolved

Interventions

TirzepatideDRUG · verified · RxNorm: tirzepatide

Sponsors & collaborators

Grace Kimlead sponsor

Vanderbilt University Medical Centercollaborator

Children's Hospitals and Clinics of Minnesotacollaborator

Seattle Children's Hospitalcollaborator

Mapped research locations

NashvilleTennessee, United States1 SeattleWashington, United States1 Saint PaulMinnesota, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06901245 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.